ARROWHEAD PHARMACEUTICALS, INC. (18) | Collaboration Agreements (2)
- Collaboration and License Agreement by and between Arrowhead Pharmaceuticals, Inc. and Horizon Therapeutics Ireland DAC, dated June 18, 2021 (Filed With SEC on August 5, 2021)
- Amendment No. 1 to Research Collaboration and Option Agreement by and between Arrowhead Pharmaceuticals, Inc. and Janssen Pharmaceuticals, Inc., dated November 14, 2019 (Filed With SEC on November 25, 2019)
